ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prior, J. J.
Right arrow Articles by Powers, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prior, J. J.
Right arrow Articles by Powers, N.

Ann Thorac Surg 1999;68:479-485
© 1999 The Society of Thoracic Surgeons

Original Articles

A sprayable hemostat containing fibrillar collagen, bovine thrombin, and autologous plasma

Jeff J. Prior, PhDa, Donald G. Wallace, PhDa, Andrew Harner, MAa, Noël Powers, BSa

a Cohesion Technologies, Palo Alto, California, USA

Address reprint requests to Dr Prior, Cohesion Technologies, Inc, 2500 Faber Place, Palo Alto, CA 94303
e-mail: jprior{at}cson.com

Background. A new sprayable hemostat, CoStasis hemostatic device (Cohesion Technologies Inc, Palo Alto, CA), consisting of collagen, thrombin, and autologous plasma was tested versus fibrin sealant and collagen hemostatic sponges. Performance was also monitored as fibrinogen and platelets were depleted from the plasma. In addition, the strength of the CoStasis gel, its sealing ability, its fibrillar structure, and its platelet-aggregating ability were investigated.

Methods. Hemostatic performance was determined with an in vivo bleeding rabbit kidney and spleen model. Differential scanning calorimetry and electron microscopy were used to analyze collagen structure. Sealing ability was determined with a burst-test apparatus.

Results. In the in vivo model, CoStasis was superior to fibrin sealant and collagen sponges in achieving a rapid time to hemostasis. The formulation continued to perform well when either platelets or fibrinogen was depleted. CoStasis formed weaker gels than fibrin sealant and could withstand only modest pressures. The collagen in the formulation had a fibrillar structure that was shown to aggregate human platelets.

Conclusions. CoStasis, with the two platelet activators collagen and thrombin in addition to the thrombin-catalyzed formation of fibrin and the sealing properties of the soft gel, provides an excellent atraumatic hemostat.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
J. G. Schoenecker, R. K. Johnson, A. P. Lesher, J. D. Day, S. D. Love, M. R. Hoffman, T. L. Ortel, W. Parker, and J. H. Lawson
Exposure of Mice to Topical Bovine Thrombin Induces Systemic Autoimmunity
Am. J. Pathol., November 1, 2001; 159(5): 1957 - 1969.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The Society of Thoracic Surgeons.